• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗菌肽CECT7121对难治性严重感染患者革兰氏阳性菌的体外疗效评估。

Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.

作者信息

Sparo M D, Jones D G, Sánchez Bruni S F

机构信息

Parasitology Division, Moredun Research Institute, Penicuik, UK.

出版信息

Chemotherapy. 2009;55(4):270-7. doi: 10.1159/000223069. Epub 2009 Jun 2.

DOI:10.1159/000223069
PMID:19494489
Abstract

BACKGROUND

Resistant Gram-positive bacteria are causing increasing concern in clinical practice. This work investigated the efficacy of AP-CECT7121 (an antimicrobial peptide isolated from an environmental strain of Enterococcus faecalis CECT7121) against various pathogenic Gram-positive bacteria.

METHODS

Strains were isolated from intensive care unit patients unresponsive to standard antibiotic treatments. Inhibitory activity of AP-CECT7121 was assessed using the agar-well diffusion method. The most resistant isolates from each species screened (Enterococcus faecium, Enterococcus faecalis,Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Clostridium perfringens and Clostridium difficile) were further examined in time-killing curve studies.

RESULTS

These bactericidal kinetic experiments demonstrated a rapid killing effect with no viable bacteria being detected within 30 and 90 min for enterococcal and streptococcal strains and 180 min for community-acquired methicillin-resistant S. aureus and C. perfringens: viable counts for C. difficile were threefold decreased after 90 min.

CONCLUSIONS

AP-CECT7121 may provide a novel strategy for treating potentially fatal clinical infections in hospitalized patients.

摘要

背景

耐革兰氏阳性菌在临床实践中日益引起关注。本研究调查了AP - CECT7121(一种从粪肠球菌环境菌株CECT7121中分离出的抗菌肽)对各种致病性革兰氏阳性菌的疗效。

方法

从对标准抗生素治疗无反应的重症监护病房患者中分离菌株。采用琼脂孔扩散法评估AP - CECT7121的抑制活性。对筛选出的每种细菌(屎肠球菌、粪肠球菌、金黄色葡萄球菌、肺炎链球菌、化脓性链球菌、产气荚膜梭菌和艰难梭菌)中耐药性最强的分离株进行时间 - 杀菌曲线研究。

结果

这些杀菌动力学实验表明,对于肠球菌和链球菌菌株,在30分钟和90分钟内未检测到活菌,对于社区获得性耐甲氧西林金黄色葡萄球菌和气荚膜梭菌,在180分钟内未检测到活菌,呈现出快速杀菌效果:艰难梭菌的活菌数在90分钟后减少了三倍。

结论

AP - CECT7121可能为治疗住院患者潜在致命的临床感染提供一种新策略。

相似文献

1
Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.新型抗菌肽CECT7121对难治性严重感染患者革兰氏阳性菌的体外疗效评估。
Chemotherapy. 2009;55(4):270-7. doi: 10.1159/000223069. Epub 2009 Jun 2.
2
In vitro efficacy of the novel peptide CECT7121 against bacteria isolated from mastitic dairy cattle.新型肽CECT7121对从患乳腺炎奶牛分离出的细菌的体外抗菌效果。
Lett Appl Microbiol. 2009 Feb;48(2):187-92. doi: 10.1111/j.1472-765X.2008.02507.x. Epub 2008 Jan 3.
3
Bactericidal Activity and Synergy Studies of Peptide AP-CECT7121 Against Multi-resistant Bacteria Isolated from Human and Animal Soft Tissue Infections.肽 AP-CECT7121 对人源和动物软组织感染分离的多耐药菌的杀菌活性和协同作用研究。
Probiotics Antimicrob Proteins. 2017 Sep;9(3):355-362. doi: 10.1007/s12602-017-9289-3.
4
Patterns of isolation of common gram positive bacterial pathogens and their susceptibilities to antimicrobial agents in Jimma Hospital.吉姆马医院常见革兰氏阳性菌病原体的分离模式及其对抗菌药物的敏感性
Ethiop Med J. 2002 Apr;40(2):115-27.
5
In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.人白蛋白或人血清的存在对达托霉素针对革兰氏阳性菌主要耐药表型菌株杀菌活性的体外影响。
J Antimicrob Chemother. 2007 Jun;59(6):1185-9. doi: 10.1093/jac/dkm078. Epub 2007 Apr 5.
6
A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico.对从波多黎各社区私立医院和大学附属医院分离出的革兰氏阳性球菌的抗菌耐药模式进行比较。
P R Health Sci J. 2003 Jun;22(2):131-6.
7
In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.替考拉宁对近期革兰氏阳性临床分离株的体外活性:2004 - 2005年欧洲前瞻性监测倡议的结果
J Antimicrob Chemother. 2008 Jul;62(1):116-21. doi: 10.1093/jac/dkn124. Epub 2008 Apr 19.
8
In vitro ciprofloxacin resistance patterns of gram-positive bacteria isolated from clinical specimens in a teaching hospital in Saudi Arabia.沙特阿拉伯一家教学医院临床标本中分离出的革兰氏阳性菌的体外环丙沙星耐药模式。
J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):54-6.
9
Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity.埃弗米霉素,一种新型寡糖抗生素:其抗菌活性、抗生素后效应及协同杀菌活性。
Drugs Exp Clin Res. 1995;21(1):7-16.
10
Antimicrobial activity of selected plant species from "the Argentine Puna" against sensitive and multi-resistant bacteria.来自“阿根廷普纳”地区的特定植物物种对敏感菌和多重耐药菌的抗菌活性。
J Ethnopharmacol. 2009 Jul 30;124(3):499-505. doi: 10.1016/j.jep.2009.05.011. Epub 2009 May 23.

引用本文的文献

1
Natural and synthetic antimicrobial peptides against anaerobic bacteria: A review of activities and mechanisms of action.天然和合成抗厌氧细菌抗菌肽:活性及作用机制综述
Probiotics Antimicrob Proteins. 2025 Sep 9. doi: 10.1007/s12602-025-10730-z.
2
Bactericidal Activity and Synergy Studies of Peptide AP-CECT7121 Against Multi-resistant Bacteria Isolated from Human and Animal Soft Tissue Infections.肽 AP-CECT7121 对人源和动物软组织感染分离的多耐药菌的杀菌活性和协同作用研究。
Probiotics Antimicrob Proteins. 2017 Sep;9(3):355-362. doi: 10.1007/s12602-017-9289-3.
3
Bio-preservation of ground beef meat by Enterococcus faecalis CECT7121.
屎肠球菌 CECT7121 对牛肉的生物保鲜作用。
Braz J Microbiol. 2013 Mar 19;44(1):43-9. doi: 10.1590/S1517-83822013005000003. eCollection 2013.